Neuropeptide Y Y5 receptor antagonists

Details Neuropeptide Y Y5 receptor antagonists Neuropeptide Y Y5 receptor antagonists

2007-12-04

2007-12-04

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S186000

Reexamination Certificate

active

10692559

ABSTRACT:
The present invention discloses compounds which, are novel receptor antagonists for NPY Y5 as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such NPY Y5 receptor antagonists as well as methods of using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.

REFERENCES:
patent: 4405644 (1983-09-01), Kabbe et al.
patent: 4623662 (1986-11-01), DeVries
patent: WO 96/16542 (1996-06-01), None
patent: WO 00/27845 (2000-05-01), None
Ko et al. “Preparation of ureidocyclohexaylmethyl . . . ” CA 142:74455 (2004).
Bonjouklian et al. “Preparation of N-isoxazoloquinolinyl . . . ” Ca 135:472724 (2001).
Murray et al. “Preparation of heteroaryl ureas . . . ” CA 143:153365 (2005).
Kushi et al. “Obesity and mild hyperinsulinemia . . . ” CA 130:192212 (1999).
Mashiko et al. “Characterization of Neuropeptide Y . . . ” Endocrinology 144(5)1793-1801 (2003).
Merck Mannual on “metabolic disorder” from web (2006).
Billington et al., Am J. Physiol., 260, R321, 1991.
Gehlert, D., Proc. Soc. Exp. Biol. Med., 218, 7, 1998.
Gerald, C. et al., Nature, 1996, 382, 168.
Hwa, J. et al., Am. J. Physiol., 277 (46), R1428, 1999.
Michel, M. et al., Pharmacol. Rev., 50, 143, 1998.
Stanley, B. and Leibowitz, S., Proc. Natl. Acad. Sci. USA 82: 3940-3943, 1985.
Wahlestedt, C., and Reis, D.J., Ann. Rev. Pharmacol. Toxicol., 32:309-352, 1993.

Affiliated with

Also associated with

Rating

Neuropeptide Y Y5 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neuropeptide Y Y5 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuropeptide Y Y5 receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3836905